Products

Recombinant Antibodies
Functional Antibodies
Anti-Drug Antibodies
- Anti-Biologic Drug Antibodies
- Anti-Small Molecule Drug Antibodies
AbPlus
Formats
Research Area
- Neuroscience Antibodies
- Cancer Stem Cell Biomarker Specific Antibodies
Engineered Antibodies
AbProcessing
- Antibody Labeling Kits
- Antibody Purification & Characterization related Products
Tetramers
Proteolytic Enzymes
Antibody-like Scaffold Proteins
Therapeutic Proteins
Soluble T Cell Receptors

Services

High Throughput Antibody Production
Custom Antibody Production & QC
Engineered Antibody Production & QC
Antibody Derivative Development
Bispecific Antibody Development
Antibody-Drug Conjugate Development
Glycoprotein Glycosylation Analysis
BCR Production & QC
Soluble TCR Production & QC

The Science of Biosimilars

Physicochemical Characterization
Biological Activity Characterization
Stability Characterization
In Vivo Non-Clinical Studies
Statistical Equivalence Analysis

One-Stop CDMO Solutions

Plasmid CDMO Solutions
- Strains & Strain Bank Establishment
- Plasmid Process Development
Antibody CDMO Solutions

Research Area

Cancer Biomarkers
Cancer Immunology
Oncoproteins
Signal Transduction in Cancer
Cell Cycle
Cell Metabolism
Apoptosis
Autophagy

Supports

FAQs
Resources
Downloads
Webinars

Company

About Us
Contact Us
Distributors
Careers
Scholarship Program
Online Inquiry
Newsletters
We Want Your Feedback!
Events

Creative Biolabs provides state-of-the-art biosimilar development and biosimilar biosafety testing services for biologics. We tailor solutions to best suit your technical and budget requirements.

Creative Biolabs distributes biosimilars development with advanced technology platforms and professionals. We are seeking partners to develop biosimilars together and accelerate the expansion of our biosimilar portfolio.

Creative Biolabs is committed to accelerating the design, engineering, validation, and biomanufacturing of engineered antibody products.

Creative Biolabs is bringing our expertise to biosimilar development programs including recombinant antibody and protein biosimilars. We are seeking partnerships with companies who are interested in co-developing biosimilars.

Creative Biolabs offers a broad range of services for development and production of antibodies and other reagents. High-quality products enable you to develop innovative solutions to advance scientific discovery.

Creative Biolabs has built integrated service platforms that cover the entire process from early-stage development to large-scale non-GMP commercialization. Seamless transition from production to downstream analysis process advances your discovery.

Creative Biolabs introduces background and research progress across a range of research areas, provides a comprehensive list of targets for therapeutic antibody discovery, and presents recommended antibody products with tested data-supported.

Creative Biolabs aims to provide you with a reliable source of antibodies and support you with our experience and expertise for your research.

Creative Biolabs is the leading supplier of antibodies for life science research. We have established ourselves as a developer and manufacturer of high-quality antibodies and other detection products.

Product Gene Keyword

Popular Searches: Recombinant Antibody MHC Tetramer T cell Receptor Scaffold Protein

Home
Gene
αVβ3 integrin

+ Filter

αVβ3 integrin

Antibody-like Scaffold Protein Products Recombinant Antibody Products Functional Antibody Products Formats More+

Anti-αVβ3 integrin Recombinant Antibody Products

Anti-αvβ3 Integrin Recombinant Antibody (TAB-705) (TAB-705)
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG2 - kappa
- Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Compare

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.

αVβ3 is a type of integrin that is a receptor for vitronectin. It consists of two components, integrin alpha V and integrin beta 3 (CD61), and is expressed by platelets. Furthermore, it is a receptor for phagocytosis on macrophages or dendritic cells. Integrin αVβ3 is potential drug target because abnormal expression of v3 is linked to the development and progression of various diseases. Inhibitors like etaracizumab may be used as antiangiogenics.

Services

Tobacco-based Expression System
Glycosylation Analysis of Therapeutic Glycoproteins
Non-GMP Antibody Production
High Throughput Antibody Production
High-Exp™ Immunotoxins Production
Bispecific Antibody Production
Antibody-drug Conjugates Production
rAb Production in Cell-Free System

Products

Hi-Affi™ Recombinant Antibody
Therapeutic Antibody
Single-domain Antibody
Immunotoxin
Immunocytokine
Intrabody
Soluble T Cell Receptor
Antibody-like Scaffold Protein
Glyco-Engineering Antibody
MHC Tetramer

Subscribe to OurNewsletter

A professional team is responsible for developing and validating products and after-sales technical support, which ensures customers receive professional assistance.

USA

Tel:
Fax:
UK

Tel:
Germany

Tel:
Email:

Cart

Inquiry

Go to compare